Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Neoplasms (Early Phase 1)
Breast Neoplasms (Early Phase 1)
Bronchial Neoplasms (Early Phase 1)
Carcinoma (Early Phase 1)
Carcinoma, Non-Small-Cell Lung (Early Phase 1)
Colorectal Neoplasms (Early Phase 1)
Digestive System Neoplasms (Early Phase 1)
Ear Neoplasms (Early Phase 1)
Endometrial Neoplasms (Early Phase 1)
Esophageal Neoplasms (Early Phase 1)
Fallopian Tube Neoplasms (Early Phase 1)
Genital Neoplasms, Female (Early Phase 1)
Head and Neck Neoplasms (Early Phase 1)
Kidney Neoplasms (Early Phase 1)
Laryngeal Neoplasms (Early Phase 1)
Liver Neoplasms (Early Phase 1)
Lung Neoplasms (Early Phase 1)
Melanoma (Early Phase 1)
Neoplasms (Early Phase 1)
Nose Neoplasms (Early Phase 1)
Osteosarcoma (Early Phase 1)
Otorhinolaryngologic Neoplasms (Early Phase 1)
Ovarian Neoplasms (Early Phase 1)
Pancreatic Neoplasms (Early Phase 1)
Peritoneal Neoplasms (Early Phase 1)
Pharyngeal Neoplasms (Early Phase 1)
Sarcoma (Early Phase 1)
Small Cell Lung Carcinoma (Early Phase 1)
Stomach Neoplasms (Early Phase 1)
Uterine Cervical Neoplasms (Early Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue